Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search
Simple search

Simple search

*
(*) mandatory field




 

Other search option(s)

67 matching term(s)

Result(s)sorted by

Caption : Accreditation =Accreditation
;

    • ITALY
    • TOSCANA
    • FIRENZE
    • Accreditation
    • Molecular cytogenetic and cytogenetic diagnosis of myelodysplastic syndromes
    • Azienda Ospedaliero Universitaria Careggi
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Accreditation
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Charité - Universitätsmedizin Berlin (CVK)
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of myeloproliferative disorders (JAK2(V617F), MPL, TET2 genes)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular analysis of refractory anemia with excess blasts (TET2 gene)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of refractory anemia (TET2 gene)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Labor Lademannbogen
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes (EGR1 (5q31), D5S23/D5S721 (5p15.2), CEP7 (7p11.1-q11.1), D7S486 (7q31), CEP8 (8p11.1-q11.1), TP53 (17p13.1), D20S108 (20q12))
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Accreditation
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • More information
    • BELGIUM
    • OOST-VLAANDEREN
    • GENT
    • Accreditation
    • Molecular cytogenetic diagnosis of myelodysplasia.
    • Ghent University Hospital - UZGent
    • More information
    • UNITED KINGDOM
    • South Yorkshire
    • SHEFFIELD
    • Accreditation
    • Molecular monitoring of donor chimerism post stem cell transplantation
    • Sheffield Children's NHS Foundation Trust
    • More information
    • UNITED KINGDOM
    • South Yorkshire
    • SHEFFIELD
    • Accreditation
    • Molecular cytogenetic diagnosis of Myelodysplastic syndromes (by karyotyping and FISH analysis)
    • Sheffield Children's NHS Foundation Trust
    • More information
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • Accreditation
    • Cytogenetic diagnosis of Myelodysplastic syndrome (by conventional karyotype)
    • Birmingham Women's NHS Foundation Trust
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Accreditation
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Gemeinschaftspraxis Dr. Prager / Dr. Junge / Dr. Hennig / Dr. Linné
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Accreditation
    • Immune phenotyping of myelodysplastic syndromes
    • Allgemeines Krankenhaus der Stadt Wien
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Accreditation
    • Molecular diagnosis of myelodysplastic syndromes ([t(X;11), t(4;11), t(6;11), t(11;19), t(10;11), t(1;11), t(11;17), t(9;11), t(1;19), t(17;19), t(12;21), t(8;21), TAL1, t(3;21), t(16;21), t(15;17), t(5;17), t(6;9), t(9;9), inv(16), t(9;22)(major + minor), t(9;12), t(5;12), t(12/22), t(3;5)] by multiplex PCR)
    • Allgemeines Krankenhaus der Stadt Wien
    • More information
    • GERMANY
    • Niedersachsen
    • HANNOVER
    • Accreditation
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes (5q31/5q15.2/7q31)
    • Medizinische Hochschule Hannover
    • More information
    • UNITED KINGDOM
    • Nottinghamshire
    • NOTTINGHAM
    • Accreditation
    • Molecular cytogenetic diagnosis of Myelodysplastic syndrome (by karyotyping and FISH)
    • Nottingham City Hospital
    • More information
    • UNITED KINGDOM
    • Surrey
    • SURREY
    • Accreditation
    • Cytogenetic diagnosis of Myelodysplastic syndrome (by conventional karyotype)
    • Institute of Cancer Research ICR
    • More information
    • UNITED KINGDOM
    • Avon
    • BRISTOL
    • Accreditation
    • Molecular cytogenetic diagnosis of Myelodysplastic syndrome (by FISH)
    • Southmead Hospital
    • More information
    • UNITED KINGDOM
    • South Glamorgan
    • CARDIFF
    • Accreditation
    • Molecular cytogenetic diagnosis of Myelodysplastic syndrome (by conventional karyotyping and FISH)
    • University Hospital of Wales
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Accreditation
    • Cytogenetic and molecular cytogenetic diagnosis of myelodysplastic syndromes (5q, 7q, 20q, +8, del(17)(p13.1))
    • BioAnalytica-GenoType SA
    • More information
    • IRELAND
    • County Dublin
    • DUBLIN
    • Accreditation
    • Molecular cytogenetic diagnosis of Myelodysplastic syndrome (by conventional karyotype and FISH)
    • Our Lady's Children's Hospital
    • More information
    • UNITED KINGDOM
    • Wiltshire
    • SALISBURY
    • Accreditation
    • Cytogenetic diagnosis of Myelodysplastic syndrome (by conventional karyotype)
    • Salisbury District Hospital
    • More information
    • UNITED KINGDOM
    • Lanarkshire
    • GLASGOW
    • Accreditation
    • Cytogenetic diagnosis of Myelodysplastic syndrome (by conventional karyotype)
    • Southern General Hospital
    • More information
    • GERMANY
    • Thüringen
    • JENA
    • Accreditation
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes (del(5q), del(7q), +8)
    • Universitätsklinikum Jena
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of myelodysplastic syndromes (GATA2 gene: sequencing)
    • CHU Paris - Hôpital Robert Debré
    • More information
    • FRANCE
    • MIDI-PYRENEES
    • TOULOUSE
    • Cytogenetic diagnosis of myeloid hemopathies
    • CHU de Toulouse - Hôpital Purpan
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Cytogenetic diagnosis of malignant hemopathies
    • CHRU de Montpellier - Hôpital Saint-Eloi
    • More information
    • ITALY
    • TOSCANA
    • PISA
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
    • More information
    • ITALY
    • FRIULI VENEZIA GIULIA
    • PORDENONE
    • Molecular cytogenetic and cytogenetic diagnosis of myelodysplastic syndromes
    • Azienda Ospedaliera Santa Maria degli Angeli
    • More information
    • ITALY
    • LOMBARDIA
    • LEGNANO
    • Molecular cytogenetic and cytogenetic diagnosis of myelodysplastic syndromes
    • Azienda Ospedaliera- Ospedale Civile di Legnano
    • More information
    • GERMANY
    • Sachsen-Anhalt
    • HALLE (SAALE)
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Universitätsklinikum Halle (Saale)
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Molecular cytogenetic and cytogenetic diagnosis of myelodysplastic syndromes
    • Azienda Ospedaliera "San Paolo" - Università degli Studi di Milano
    • More information
    • ITALY
    • VENETO
    • VICENZA
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes
    • ULSS 6 "Vicenza"
    • More information
    • PORTUGAL
    • SUL
    • LISBOA
    • Molecular cytogenetic diagnosis of myelodysplastic syndrome (FISH for 5q31-q33, 7q22-q35 and 20q12)
    • Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of myelodysplastic syndromes. EVI1 gene
    • Hospital Universitario La Fe - Campanar
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes - deletions 5q31, 7q31 and 20q12
    • Instituto Português de Oncologia do Porto, EPE / IPOFG - CRO Porto
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular cytogenetic diagnosis of malignant haemopathies
    • Instituto Português de Oncologia do Porto, EPE / IPOFG - CRO Porto
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Molecular cytogenetics diagnosis of acute non lymphoblastic leukemia and myelodysplastic syndromes
    • Diagnostic Genetic Center
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes (MECOM gene / FISH)
    • Hospital Universitario La Fe - Campanar
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of myelodysplastic syndromes and myeloid hemopathy (TET2 gene / PCR)
    • Hospital Universitario La Fe - Campanar
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular cytogenetic diagnosis of acute myeloid leukemia and myelodysplastic syndromes (FISH)
    • Hospital Universitario La Fe - Campanar
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of refractory anemia (TET2 gene: Sequencing of the entire coding region)
    • CGC Genetics / Centro de Genética Clínica
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes. EVI1, NUP214, DEK genes
    • Hospital del Mar
    • More information
    • SPAIN
    • Comunidad Valenciana
    • SANT JOAN D'ALACANT
    • Molecular cytogenetics diagnosis of myelodysplastic syndromes (FISH 5q31-5q34; 7q31, CEP 8, del(20q12))
    • Centro Inmunológico de Alicante (CIALAB)
    • More information
    • SLOVENIA
    • SLOVENIA
    • LJUBLJANA
    • 'Cytogenetic diagnosis of myelodysplastic syndromes (deletion 5q, 7q and 20q; FISH and conventional karyotype)'
    • University Medical Center Ljubljana
    • More information
    • UNITED KINGDOM
    • Tayside
    • DUNDEE
    • Cytogenetic diagnosis of Myelodysplastic syndrome
    • Ninewells Hospital
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Cytogenetic/ molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Diagenom GmbH
    • More information
    • FRANCE
    • LORRAINE
    • METZ
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Molecular cytogenetic diagnosis of Myelodysplastic syndrome (MECOM: by FISH analysis)
    • Great Ormond Street Hospital for Children, NHS Foundation Trust
    • More information
    • UNITED KINGDOM
    • Dorset
    • BOURNEMOUTH
    • Molecular cytogenetic diagnosis of Myelodysplastic syndrome (by FISH analysis)
    • Royal Bournemouth Hospital
    • More information
    • SPAIN
    • Asturias
    • OVIEDO
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes (FISH)
    • Hospital Universitario Central de Asturias
    • More information
    • FRANCE
    • ALSACE
    • STRASBOURG
    • Cytogenetic diagnosis of myeloid hemopathies (classical caryotype and FISH)
    • CHU de Strasbourg - Hôpital de Hautepierre
    • More information
    • ITALY
    • PUGLIA
    • LECCE
    • Cytogenetic and molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Presidio Ospedaliero "Vito Fazzi" - ASL LE
    • More information
    • ITALY
    • UMBRIA
    • PERUGIA
    • Cytogenetic and molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Università degli Studi di Perugia - Ospedale S. Maria della Misericordia
    • More information
    • ITALY
    • CALABRIA
    • REGGIO CALABRIA
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Azienda Ospedaliera BMM
    • More information
    • ITALY
    • PIEMONTE
    • CANDIOLO
    • Cytogenetic and molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Istituto per la Ricerca e la Cura del Cancro
    • More information
    • SPAIN
    • Canarias
    • SANTA CRUZ DE TENERIFE
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes by FISH analysis (5q31, 7q31, 8p11.1-q11.1, 20q12)
    • Hospital Universitario de Canarias
    • More information
    • SPAIN
    • Galicia
    • A CORUÑA
    • Molecular cytogenetics diagnosis of myelodysplastic syndromes (del (5q) (7q) (20q) - FISH)
    • Complejo Hospitalario Universitario A Coruña
    • More information
    • GREECE
    • THESSALONIKI
    • THESSALONIKI
    • Molecular diagnosis of myelodysplastic syndromes
    • Theagenion Cancer Centre of Thessaloniki
    • More information
    • BELGIUM
    • VLAAMS BRABANT
    • LEUVEN
    • Molecular cytogenetic diagnosis of myelodysplasia.
    • University Hospitals Leuven - Gasthuisberg
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Molecular diagnosis of acute myelomonocytic leukemia and myelodysplastic syndromes : search for CBFB/MYH11 fusion gene
    • Karaiskakio foundation
    • More information
    • MOROCCO
    • Rabat
    • RABAT
    • Molecular cytogenetics diagnosis of acute lymphoblatic and myeloblastic leukaemia, myeloproliferative and myelodysplastic syndromes
    • Institut National d'Hygiène
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • KAISERSLAUTERN
    • Cytogenetic and molecular cytogenetic diagnosis of myelodysplastic syndromes (del5q31/del7q31/+8/del20q12)
    • Med-Biolog-Labor
    • More information
    • ITALY
    • CAMPANIA
    • NAPOLI
    • Molecular cytogenetic diagnosis of myelodysplastic syndromes
    • Azienda Ospedaliera "A. Cardarelli"
    • More information
    • GERMANY
    • Schleswig-Holstein
    • KIEL
    • Molecular cytogenetic and cytogenetic diagnosis of myelodysplastic syndromes (EGR1 (5q31), EZH2 (7q36), hTERT (5p15), MLL5 (7q22), MYBL2 (20q13), MYC (8q24), PTPRT (20q12), TET2 (4q24))
    • Praxis Dr. Lana Harder
    • More information
    • SPAIN
    • Cataluña
    • BADALONA
    • Molecular and molecular cytogenetics diagnosis of myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality (RPS14 gene, locus 5q31 / FISH, SNP ARRAYS)
    • IMPPC - Instituto de Medicina Predictiva y Personalizada del Cáncer
    • More information